Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis

Decreased fibrinolytic function favors the development of pulmonary fibrosis. Thrombin-activatable fibrinolysis inhibitor (TAFI) is a strong suppressor of fibrinolysis, but its role in lung fibrosis is unknown. Therefore, we compared bleomycin-induced lung fibrosis in TAFI-deficient, heterozygous, a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fujimoto, Hajime, Gabazza, Esteban C., Taguchi, Osamu, Nishii, Yoichi, Nakahara, Hiroki, Bruno, Nelson E., D’Alessandro-Gabazza, Corina N., Kasper, Michael, Yano, Yutaka, Nagashima, Mariko, Morser, John, Broze, George J., Suzuki, Koji, Adachi, Yukihiko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Investigative Pathology 2006
Aiheet:
Original Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1606569/
https://ncbi.nlm.nih.gov/pubmed/16565485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2006.050610
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia